Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
To evaluate the effectiveness of an intervention with a mobile adherence platform, compared to physician - or nurse - guided standard of care, to improve medication adherence to rivaroxaban in subjects who have recently initiated treatment with rivaroxaban for stroke prevention in atrial fibrillation based on an assessment of the PDC, (proportion of days covered) of rivaroxaban treatment.
Stephanie Porenta, RN: 425.467.3986, Stephanie.Porenta@overlakehospital.org
Clinical Trial Categories
*NOTE: THIS TRIAL IS NO LONGER ACCEPTING NEW PATIENTS.